← Back to headlines
Oxford Begins First Human Trials for Bundibugyo Ebola Vaccine
The University of Oxford has officially launched the first human trial for a vaccine specifically targeting the Bundibugyo strain of Ebola, marking a critical step in global efforts to combat the deadly virus. This trial represents a significant advancement in developing defenses against this particular strain.
13 Jul, 22:24 — 14 Jul, 22:25
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (46/100)3 sources25/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left1
Left (1)
japan-times
Center2
Center (2)
actualite-cdmyjoyonline
Right
Far R
Geographic diversity— 3 regions13/34
DR Congo1Japan1Ghana1
Sources
Showing 3 of 3 sources
japan-timesMostly Factual42d ago
First human trial of Bundibugyo Ebola vaccine begins
The early-stage trial will enroll 50 healthy adults to assess the vaccine's safety and immune response.
Read full article →myjoyonlineMixed42d ago
Oxford begins first human trial of Bundibugyo Ebola vaccine
The University of Oxford has launched the first human trial of a vaccine against Bundibugyo ebolavirus, seeking to accelerate efforts to combat an outbreak spreading in the Democratic Republic of Congo and Uganda.
By Abubakar Ibrahim
Read full article →actualite-cdMixed41d ago
Oxford launches first human trials for Bundibugyo Ebola vaccine - MSN
Oxford launches first human trials for Bundibugyo Ebola vaccine MSN
Read full article →Coverage Timeline
First report: myjoyonline · 13 Jul, 22:24|Full coverage: 3 · 1d|Window: 1d
Left-leaningCenterRight-leaning
